Recall of some batches of Ventolin and Asmol Inhalers

The Acting Chief Health Officer of NSW, Dr Tony Penna advised on 24 December that GlaxoSmithKline (GSK) has initiated a retail level recall of 10 batches of Ventolin and Asmol Inhalers due to a fault in the delivery mechanism leading to an inconsistent dose. In devices that are affected, the dose of the active medication - salbutamol - may not be delivered in full. In some cases, approximately one third of the normal dose may be delivered per puff of the inhaler. Read the full media release here and more information here.

Article Posted:

Monday, 07 January 2013